129 related articles for article (PubMed ID: 19688314)
1. Effects of Xuezhikang and pravastatin on circulating endothelial progenitor cells in patients with essential hypertension.
Lu L; Zhou JZ; Wang L; Zhang TX
Chin J Integr Med; 2009 Aug; 15(4):266-71. PubMed ID: 19688314
[TBL] [Abstract][Full Text] [Related]
2. Effects of combined therapy of Xuezhikang Capsule and Valsartan on hypertensive left ventricular hypertrophy and heart rate turbulence.
Gong C; Huang SL; Huang JF; Zhang ZF; Luo M; Zhao Y; Jiang XJ
Chin J Integr Med; 2010 Apr; 16(2):114-8. PubMed ID: 20473735
[TBL] [Abstract][Full Text] [Related]
3. [Effects of combined application of xuezhikang capsule with hypotensive drugs on arterial compliance and smoothness of the dynamic blood pressure].
Zhu ZT; Ma YX; Wang J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 May; 30(5):463-6. PubMed ID: 20681273
[TBL] [Abstract][Full Text] [Related]
4. [Effects of xuezhikang at different doses on patients suffering from acute coronary syndrome after percutaneous coronary intervention].
Jiang FY; Sun LP; Yang J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Dec; 31(12):1607-10. PubMed ID: 22384544
[TBL] [Abstract][Full Text] [Related]
5. Pravastatin decreases blood pressure in hypertensive and hypercholesterolemic patients receiving antihypertensive treatment.
Kawano H; Yano K
Circ J; 2006 Sep; 70(9):1116-21. PubMed ID: 16936421
[TBL] [Abstract][Full Text] [Related]
6. Effects of an angiotensin II receptor blocker on the impaired function of endothelial progenitor cells in patients with essential hypertension.
Suzuki R; Fukuda N; Katakawa M; Tsunemi A; Tahira Y; Matsumoto T; Ueno T; Soma M
Am J Hypertens; 2014 May; 27(5):695-701. PubMed ID: 24200748
[TBL] [Abstract][Full Text] [Related]
7. Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial.
Mancia G; Parati G; Revera M; Bilo G; Giuliano A; Veglia F; Crepaldi G; Zanchetti A
BMJ; 2010 Mar; 340():c1197. PubMed ID: 20339154
[TBL] [Abstract][Full Text] [Related]
8. Effect of folic acid combined with pravastatin on arteriosclerosis in elderly hypertensive patients with lacunar infarction.
Li C; Bu X; Liu Y
Medicine (Baltimore); 2021 Jul; 100(28):e26540. PubMed ID: 34260532
[TBL] [Abstract][Full Text] [Related]
9. Effects of withdrawal of Xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with coronary artery disease.
Hu CL; Li YB; Tang YH; Chen JB; Liu J; Tang QZ; Zhang QH; Huang CX
Cardiovasc Drugs Ther; 2006 Jun; 20(3):185-91. PubMed ID: 16775668
[TBL] [Abstract][Full Text] [Related]
10. Effect of olmesartan medoxomil on number and survival of circulating endothelial progenitor cells and calcitonin gene related peptide in hypertensive patients.
Calò LA; Dal Maso L; Pagnin E; Ravarotto V; Facco M; Boscaro E; Maiolino G; Pessina AC; Rossi GP
J Hypertens; 2014 Jan; 32(1):193-9. PubMed ID: 24309489
[TBL] [Abstract][Full Text] [Related]
11. Effects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study.
Moriarty PM; Roth EM; Karns A; Ye P; Zhao SP; Liao Y; Capuzzi DM; Bays HE; Zhang F; Liu S; Reichman AJ; Brusco OA; Lu G; Lerman S; Duan Z; Guo S; Liu PL; Zhao J; Zhang Y; Li S
J Clin Lipidol; 2014; 8(6):568-575. PubMed ID: 25499939
[TBL] [Abstract][Full Text] [Related]
12. Potential protective effect of long-term therapy with Xuezhikang on left ventricular diastolic function in patients with essential hypertension.
Ye P; Wu CE; Sheng L; Li H
J Altern Complement Med; 2009 Jul; 15(7):719-25. PubMed ID: 19552598
[TBL] [Abstract][Full Text] [Related]
13. Toxicological evaluation of, red rice yeast extract, Xuezhikang: Acute, 26-week chronic and genotoxicity studies.
Gao Y; Chen X; Li C; Wang H; Tian J; Fu F
Regul Toxicol Pharmacol; 2020 Jul; 114():104654. PubMed ID: 32278069
[TBL] [Abstract][Full Text] [Related]
14. The endothelial status reflected by circulating endothelial cells, circulating endothelial progenitor cells and soluble thrombomodulin in patients with mild and resistant hypertension.
Budzyń M; Gryszczyńska B; Boruczkowski M; Kaczmarek M; Begier-Krasińska B; Osińska A; Bukowska A; Iskra M; Kasprzak MP
Vascul Pharmacol; 2019 Feb; 113():77-85. PubMed ID: 30590133
[TBL] [Abstract][Full Text] [Related]
15. Effect of antihypertensive treatment on circulating endothelial progenitor cells in patients with mild essential hypertension.
de Ciuceis C; Pilu A; Rizzoni D; Porteri E; Muiesan ML; Salvetti M; Paini A; Belotti E; Zani F; Boari GE; Rosei CA; Rosei EA
Blood Press; 2011 Apr; 20(2):77-83. PubMed ID: 21114380
[TBL] [Abstract][Full Text] [Related]
16. Sympathetic predominance is associated with impaired endothelial progenitor cells and tunneling nanotubes in controlled-hypertensive patients.
de Cavanagh EM; González SA; Inserra F; Forcada P; Castellaro C; Chiabaut-Svane J; Obregón S; Casarini MJ; Kempny P; Kotliar C
Am J Physiol Heart Circ Physiol; 2014 Jul; 307(2):H207-15. PubMed ID: 24858852
[TBL] [Abstract][Full Text] [Related]
17. Effect of pravastatin on endothelial function and endothelial progenitor cells in healthy postmenopausal women.
Paradisi G; Bracaglia M; Basile F; Di'Ipolito S; Di Nicuolo F; Ianniello F; Quagliozzi L; Donati L; Labianca A; Di Cesare C; Viggiano M; Biaggi A; De Waure C; Andreotti F; Di Simone N; Caruso A
Clin Exp Obstet Gynecol; 2012; 39(2):153-9. PubMed ID: 22905454
[TBL] [Abstract][Full Text] [Related]
18. Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathway.
Zhao SP; Li R; Dai W; Yu BL; Chen LZ; Huang XS
PLoS One; 2017; 12(9):e0184949. PubMed ID: 28934253
[TBL] [Abstract][Full Text] [Related]
19. [Effects of Danshen on number and activity of endothelial progenitor cells of patients with hypercholesterolemia].
Ji KT; Zhang HQ; Tang JF; Li HY
Zhongguo Zhong Yao Za Zhi; 2007 Jun; 32(12):1214-7. PubMed ID: 17802891
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness and safety of low dose pravastatin in elderly hypertensive hypercholesterolemic subjects on antihypertensive therapy.
Chan P; Lee CB; Lin TS; Ko JT; Pan WH; Lee YS
Am J Hypertens; 1995 Nov; 8(11):1099-104. PubMed ID: 8554733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
